Parexel aligns with Japan-based cancer institute to advance clinical research

By Melissa Fassbender

- Last updated on GMT

(Image: iStock/dk_photos)
(Image: iStock/dk_photos)

Related tags Medicine

Parexel's alliance with the Osaka International Cancer Institute focuses on supporting efficient patient recruitment and advancing new cancer treatments.

Through this alliance, the Osaka International Cancer Institute will gain access to novel oncology and hematology treatments in development, allowing Parexel and the Institute to make a strong contribution to clinical trials and the advancement of new cancer treatments​,” a Parexel spokesperson told Outsourcing-Pharma.com.

Additionally, the alliance provides local and global sponsors with increased access to patients, which the company said will enable better recruitment for clinical trials.

Parexel – which was acquired in June​ by a private equity firm – has been operating in Japan​ since 1995. The company has more than 1,300 employees based in Tokyo, Kobe, and Osaka.

The Osaka International Cancer Institute is made up of a hospital division, research division, and cancer control center. It provides various treatment options, including surgery, chemotherapy, radiotherapy, and immunotherapy treatments.

Oncology is the largest therapeutic area in clinical trials today​,” the spokesperson added. “This alliance is an important step forward in advancing the development of new therapies in this difficult disease​.”

Parexel did not provide any comment on the duration of the alliance.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Related suppliers

Follow us

Products

View more

Webinars